Resverlogix Corp. has announced key scientific data was presented in an oral presentation highlighting the novel features of RVX-208 at the American Heart Association Scientific Meeting. The presentation titled “Compound RVX-208 Modulates HDL-C Levels and Function in Non-human Primates and in Early Human Trials” was presented by Dr. Jacques Genest.
Navigation
Daily News
- Health ad campaigns emerge in final days of debate
- BioVigil’s second generation hand hygiene monitoring system released
- Antiseptic Baths Help Fight ‘Superbug’ Infections
- Women and Hair Loss
- Slate Looks At ‘Contraceptive Pioneers’ And New Contraceptives In Development
Translator
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  |  |  |
 |  |  |  |  |  |  |  | ||
| By N2H | |||||||||